Latest News

Medline to Acquire Ecolab’s Surgical Solutions Division in Nearly $1 Billion Deal

In a strategic move aimed at bolstering its presence in the operating room, hospital supply giant Medline has announced plans to acquire Ecolab’s surgical solutions division at a price just shy of $1 billion. The deal encompasses a range of critical operating room products, including Ecolab’s Microtek lines of sterile drapes for covering patients and equipment, as well as its fluid temperature management system. Medline, a leading provider of medical supplies and solutions, views the acquisition as an opportunity to expand its portfolio and enhance its design and development capabilities in original equipment manufacturing. Jim Pigott, President and Chief Operating Officer of Medline, expressed confidence in the acquisition, citing the strong reputation of Ecolab’s products in protecting

ONO Pharmaceutical to Acquire Deciphera Pharmaceuticals in $2.4 Billion Merger

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a prominent biopharmaceutical entity with a focus on pioneering medicines for cancer treatment, has announced its forthcoming acquisition by ONO Pharmaceutical Co., Ltd. (ONO) in a definitive merger agreement. The acquisition, valued at $2.4 billion, will be executed
Articles

Info-Tech Releases Responsible AI Primer for Healthcare and Public Health Sectors

In response to the growing integration of artificial intelligence (AI) in healthcare and public health sectors, Info-Tech Research Group has unveiled a comprehensive resource titled "Responsible AI Primer and Playbook for Public Health and Healthcare Organizations." This initiative seeks to assist organizations in navigating the intricate landscape of AI implementation while upholding ethical standards and ensuring data security. Neal Rosenblatt, principal research director at Info-Tech Research Group, emphasized the necessity for healthcare entities to balance innovation with ethical considerations. He stated, "As AI becomes more deeply embedded in public health and healthcare systems, ensuring responsible AI practices becomes paramount – not merely as a choice but as an ethical

New Therapeutic Device Offers Hope in the Fight Against Pediatric Sepsis

In the ongoing battle against sepsis, a life-threatening condition triggered by a dysregulated response to infection, a breakthrough therapeutic device has emerged to offer a ray of hope, particularly for pediatric patients. Developed at the University of Michigan in collaboration with SeaStar Medical, the selective
Specialities

Tailored Physical Therapy Program Shows Significant Improvements in Axial Spondyloarthritis Patients

A recent study published in the journal Therapeutic Advances in Musculoskeletal Disease has demonstrated the efficacy of a two-week tailored physical therapy program in significantly improving spinal mobility and function among individuals with axial spondyloarthritis (axSpA). Led by a research team at Ruhr-University Bochum in Germany, the study utilized a novel electronic device called Epionics SPINE (ES) to objectively evaluate spinal mobility, providing valuable clinical evidence for the effectiveness of exercise-based interventions in managing axSpA. Axial spondyloarthritis is a chronic arthritis primarily affecting the joints in the spine, pelvis, and chest. It encompasses both nonradiographic axSpA (nr-axSpA), where no visible damage is observed on X-rays, and radiographic axSpA

Revolutionizing Stroke Rehabilitation: The Promise of Telerehabilitation

In the aftermath of a stroke, individuals often confront formidable challenges, particularly in the restoration of lower body mobility and the pursuit of regained independence. These obstacles not only encompass physical limitations but also extend to mental well-being and overall quality of life. Recognizing this
Medical Equipment

HORIBA Medical Launches Next Neneration HELO Fully Automated Modular Hematology Solution

Montpellier, France (4 January 2024) – HORIBA Medical has launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved. Following the success of HORIBA Medical’s previous HELO, this new generation high-end hematology range has been designed in consultation with customers to further improve and cover all needs of high throughput fully automated hematology. HELO 2.0 offers a highly flexible and efficient modular hematology solution that is fully scalable with many possible configurations for mid to large-scale laboratories. HORIBA Medical’s advanced technologies embedded in the platform’s Yumizen H2500 and Yumizen H1500 hematology analyzers ensure high quality analytical performance. This includes 360-degree sample mixing without any premixing required.

Pulmonary embolism startup Flow Medical raises $2M in friends-and-family round

Flow Medical has recently secured $2 million in a funding round primarily from friends and family. The Chicago-based company is actively engaged in the development of an innovative thrombolysis catheter designed to address acute pulmonary embolism (PE). The secured funds will be directed towards research and

Olympus Announces Launch of Next Generation Electrosurgical Generator

Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced market availability of its newest electrosurgical generator for use in the treatment of bladder cancer and enlarged prostate. The ESG-410 Electrosurgical Generator supports options
Product Focus

Stryker Announces Prophecy Footprint as Part of its Prophecy Surgical Planning Platform

Stryker, a prominent name in medical technology, has introduced Prophecy Footprint, a new addition to its Prophecy Surgical Planning platform, designed to cater specifically to foot and ankle surgeries, including complex procedures like total ankle replacement. This development marks a significant advancement in addressing the challenges often encountered in traditional surgical planning methods. Traditional surgical planning tends to focus narrowly on the targeted joint, often overlooking potential issues in surrounding areas. However, with approximately 70% of patients requiring additional procedures during total ankle replacement, a more comprehensive approach becomes imperative. Prophecy Footprint seeks to bridge this gap by offering a more holistic perspective on surgical planning.

FDA clears next-generation cardiovascular, thoracic CT scanners

Arineta Cardio Imaging has recently announced a significant milestone with the FDA 510(k) clearance and the subsequent launch of its advanced cardiovascular CT scanners. The cutting-edge system, named SpotLight, has been meticulously crafted to cater specifically to cardiovascular CT imaging needs. What sets this

Laser-assisted robotic knee surgery advances orthopaedic treatment

Robotic-assisted knee replacement surgery with laser technology is garnering attention as a groundbreaking advancement in orthopaedic care. With its array of benefits for patients and surgeons alike, this cutting-edge approach is transforming the landscape of knee surgeries. In an interview, Dr. Anush Rao, Specialist
Pharmaceuticals

Breakthroughs in Antiviral Drug Development: New Hope for Influenza and Dengue Patients

In the ongoing battle against viral infections such as influenza and dengue fever, recent advancements in antiviral drug development offer promising prospects for treatment and prevention. A collaborative effort between researchers from St. Jude Children’s Research Hospital, University of Houston, Tufts University School of Medicine, and Fox Chase Cancer Center has resulted in the creation of a groundbreaking drug capable of preventing flu-induced lung injury. This development, published in the prestigious journal Nature, marks a significant milestone in combating the potentially life-threatening consequences of influenza virus infection. The newly developed drug, named UH15-38, demonstrates a unique ability to strike a delicate balance between suppressing excessive inflammation and

Paxlovid: A Vital Tool in Preventing Severe COVID-19, Yet Underutilized

Despite the availability of Paxlovid, a potent medication designed to prevent mild-to-moderate COVID-19 infections from escalating into more severe conditions, recent studies have revealed a significant under-prescription of this drug among eligible patients. With its efficacy demonstrated in clinical trials and its

How a Viral Peptide Drug Interacts with Liver Cells to Combat Hepatitis

Hepatitis B virus (HBV) and hepatitis D virus (HDV) infections pose significant threats to global health, contributing to liver-related ailments such as cirrhosis and hepatocellular carcinoma. Despite strides in treatment, these viruses continue to challenge medical researchers. However, a recent breakthrough published
Campaigns & Recent Studies

Study Shows Severe COVID-19 Linked to Higher Risk of Long-Term Psychiatric and Neurologic Disorders

A recent study has shed new light on the long-term effects of COVID-19, suggesting that severe cases of the illness are associated with a significantly increased risk of psychiatric and neurologic disorders in the year following infection. The findings challenge previous assumptions about the impact of COVID-19 on mental and neurological health and underscore the importance of understanding the complexities of the disease's aftermath. Understanding the Study The study, led by senior author Anders Hviid, MSc, DrMedSci, head of the department and professor of pharmacoepidemiology at the Statens Serum Institut in Copenhagen, Denmark, drew on data from the Danish National Patient Registry. Researchers analyzed records of hospital contacts from January 2005 to January 2023, comparing

Recent Study Highlights Progress in Breast Cancer Prevention

In the realm of breast cancer prevention, the exploration of dietary interventions and their interaction with the gut microbiome has unveiled promising avenues for reducing disease risk. Recent research, including a study published in Microbiology Spectrum, sheds light on the potential of flaxseed—a humble yet potent
Diet & Nutrition

Food SENSE offers new ways of assessing and tackling malnutrition in Uganda.

CGIAR’s Sustainable Animal Productivity and Livelihoods, Nutrition and Gender inclusion Initiative (SAPLING) has developed a tool for assessing, identifying and responding to food and nutrition security problems in developing countries. The Food Security, Environments and Nutrition: Structured Evidence (FoodSENSE), is a decision support process developed by SAPLING researchers to aid decision makers in identifying barriers to improved food security and nutrition, and then to structure dialogue for prioritization of appropriate solutions for target demographic groups. The tool provides site-specific information on foods consumed, where they are sourced and the nutritional outcomes. It is also used to evaluate food systems and environments, including markets, value chains and socio-cultural

What Are The Signs That Iron Pills Are Working?

The signs that iron pills are working vary from person to person. Some people may notice an improvement in energy and other anemia symptoms. People without noticeable anemia symptoms may see little change. People often begin responding to iron pills within 2 weeks. A doctor can monitor if supplementation is working by

The “Medical Bypass”: New Drugs to Strike Obesity

The FDA has granted Mounjaro, drug that showed comparable potential to gastric bypass surgery, a Fast Track designation to treat obesity. In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. In
Country Reports

Egypt to Boost Health and Education Spending in Next Fiscal Year

In a bid to enhance public services and realize the objectives set forth in Egypt’s Vision 2030, the country's Finance Minister, Mohamed Maait, announced plans to significantly increase allocations for the health and education sectors in the upcoming general budget. According to Maait, Egypt is poised to allocate 495.6 billion pounds ($10.4 billion) to the health sector in the next fiscal year, marking a substantial 24.9 percent annual growth compared to the current fiscal period. This move underscores the nation’s commitment to improving medical services for its citizens, aligning with the overarching goals outlined in Egypt’s long-term development strategy, Vision 2030. Additionally, allocations for the education sector are set to receive a considerable boost, reaching 858.3 billion
Events

Arab Health anticipates 3,000 companies from 70 countries for its next edition in January

The 2023 edition of Arab Health will return to the Dubai World Trade Centre from 30th January – 2nd February under the show's theme, 'Innovation and Sustainability in Healthcare', the organizers said. Exhibitor companies are also anticipated to rise, increasing from 2,828 to over 3,000 from 70 countries, according to Informa Markets. Arab Health has underscored its position as the epicenter of healthcare trade and reaffirmed its support for global businesses and governments by securing AED2.8 billion worth of healthcare industry-related contracts, according to a GRS Explore Exhibitor Survey during the 2022 edition, which was held in Dubai in January. The exhibition plays an integral role in supporting UAE Government initiatives such as ‘Make it in the Emirates’, a platform for developing